Catalysts Abound for Biotech ETFs
Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR S&P Biotech…
XBI
Alkermes FDA Refusal: Biotech ETFs Dragged Down
Biotechnology stocks and biotech ETFs were among the worst performing areas of the markets Monday as Alkermes (NasdaqGS: ALKS) shares plunged after…
Healthcare Dip Could be a Buying Opportunity
The Health Care Select Sector SPDR (NYSEArca: XLV), the largest exchange traded fund dedicated to the S&P 500’s third-largest sector weight, tumbled…
Biotech ETFs Pop on Celgene, Juno Deal
Biotechnology sector-related ETFs surged Monday after Celgene (NasdaqGS: CELG) said it will acquire Juno Therapeutics (NasdaqGS: JUNO) to expand its cancer treatment…
Biotech Slump Could be a Buying Opportunity
Biotechnology stocks and ETFs are slumping in the fourth quarter. For example, the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF…
Biotech Decline Could be a Buying Opportunity
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF by assets, and its equal-weight rival, the SPDR S&P Biotech ETF (NYSEArca:…
Why Healthcare Sector is a Great November Play
It is already the second-best sector this year behind technology, but the healthcare sector has a penchant for performing well in November.…
Hot Biotech Stocks, ETFs Can Keep Surging
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF by assets, and its equal-weight rival, the SPDR S&P Biotech ETF (NYSEArca:…
Bullish Biotech Bets After Positive Attention
Biotechnology ETFs have been getting plenty of positive attention in recent weeks, a trend that certainly extends to the SPDR S&P Biotech…
A Good Time to Own Biotech ETFs
The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotech ETFs, has already notched some impressive year-to-date returns, but XBI’s…
Evaluating the Biotech ETF Rally
The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotech ETFs, is getting in on the sector’s resurgence. XBI, an…
Biotech ETF Investing is Hot, Can Get Hotter
Up more than 42% year-to-date, the SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotechnology ETFs, is one of this…
Biotech ETFs Remain Bell of the Ball
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotechnology exchange traded fund by assets, and its equal-weight rival, the SPDR S&P Biotech…
Biotech ETF Investing is Starting to Look Good – Here’s Why
The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotechnology exchange traded funds, is getting in on the sector’s resurgence.…